Urinary Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Urinary Catheters Pipeline Market Report Overview

A urinary catheter is a tube system to drain and collect urine from the bladder. The urinary catheters pipeline market research report provides comprehensive information about the urinary catheters pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Key Segments ·       Foley Catheters

·       External Urinary Catheters

·       Suprapubic Catheters

Key Territories ·       The US

·       Europe

·       China

·       Taiwan

·       Singapore

Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       MDL

·       HSA

Leading Companies ·       All India Institute of Medical Sciences

·       Aurie

·       Biocrede Inc

·       BioModics ApS

·       Brighton Development LLC

·       Camstent Ltd

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Urinary Catheters Pipeline Market Segments

Some of the key segments in the urinary catheters pipeline market are foley catheters, external urinary catheters, and suprapubic catheters. As of May 2023, foley catheters have the highest number of pipeline products.

Urinary Catheters Pipeline Market Analysis, by Segments, 2023 (%)

Urinary Catheters Pipeline Market Analysis, by Segments, 2023 (%)

For more segment insights into the urinary catheters pipeline market, download a free report sample

Urinary Catheters Pipeline Market Segmentation by Territories

Some of the territories in the urinary catheters pipeline market are the US, Europe, China, Taiwan, and Singapore among others. As of May 2023, the US has the highest number of pipeline products.

Urinary Catheters Pipeline Market Analysis, by Territories, 2023 (%)

Urinary Catheters Pipeline Market Analysis, by Territories, 2023 (%)

For more territory insights into the urinary catheters pipeline market, download a free report sample

Urinary Catheters Pipeline Market Segmentation by Regulatory Paths

Some of the regulatory paths in the urinary catheters pipeline market are 510(k), NMPA, MDL, HSA, and CE among others. As of May 2023, 510(k) is the most followed pathway for pipeline products.

Urinary Catheters Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

Urinary Catheters Pipeline Market Analysis, by Regulatory Paths, 2023 (%)

For more regulatory path insights into the urinary catheters pipeline market, download a free report sample

Urinary Catheters Pipeline Market – Competitive Landscape

Some of the key companies in the urinary catheters pipeline market are All India Institute of Medical Sciences, Aurie, Biocrede Inc, BioModics ApS, Brighton Development LLC, and Camstent Ltd among others.

AIIMS: All India Institute of Medical Sciences (AIIMS) is a medical institution that provides medical education, biomedical research, and healthcare services. It offers research services, teaching services, medical services, nursing services, and laboratory services among others. AIIMS conducts research in the field of neurosciences, genetics, and on computer simulation of hormone-receptor interaction. It applies DNA recombinant technology, immunology, and electron microscopy to study diseases such as leprosy, malaria, tuberculosis, diabetes, diarrhea, hepatitis, fluorosis, and iodine deficiency. AIIMS is headquartered in New Delhi, India.

Segments Covered in the Report

Urinary Catheters Pipeline Market Segments Outlook

  • Foley Catheters
  • External Urinary Catheters
  • Suprapubic Catheters

Urinary Catheters Pipeline Market Territories Outlook

  • The US
  • Europe
  • China
  • Taiwan
  • Singapore

Urinary Catheters Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • NMPA
  • CE
  • MDL
  • HSA

Scope

  • Extensive coverage of the urinary catheters under development
  • Reviews details of major pipeline products which include, product description, licensing and collaboration details, and other developmental activities
  • Reviews the major players involved in the development of urinary catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of urinary catheters under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

All India Institute of Medical Sciences
Aurie
Biocrede Inc
BioModics ApS
Brighton Development LLC
Camstent Ltd
Ceragenix Pharmaceuticals, Inc. (Inactive)
Chain Antimicrobials Ltd
Coloplast A/S
Control Flo Medical LLC
ConvaTec Group Plc
Dongguan TT Medical Inc
Enox Biopharma Inc (Inactive)
Flat Medical Inc
Flume Catheter Co Ltd
FocusStart LLC
Ingenion Medical Ltd
InterVaal Pte Ltd
Laborie Medical Technologies Inc
Leading Age Supplies LLC
Montana State University
N8 Medical LLC
Olympus Endo Technology America Inc
OTU Medical Inc
Provenmed
Pyriscence LLC
Riocath Global AS
Sharklet Technologies Inc
The University of Nottingham
Tractivus SL
University of Amsterdam
University of California San Diego
University of South Florida
University of Texas Health Science Center at San Antonio
University of Utah
UroDeflect
UroDev Medical
Xennovate Medical LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 6

|1.2 List of Figures 9

2 Introduction 10

2.1 Urinary Catheters Overview 10

3 Products under Development 11

3.1 Urinary Catheters – Pipeline Products by Stage of Development 11

3.2 Urinary Catheters – Pipeline Products by Segment 12

3.3 Urinary Catheters – Pipeline Products by Territory 13

3.4 Urinary Catheters – Pipeline Products by Regulatory Path 14

3.5 Urinary Catheters – Pipeline Products by Estimated Approval Date 15

3.6 Urinary Catheters – Ongoing Clinical Trials 16

4 Urinary Catheters – Pipeline Products under Development by Companies 17

4.1 Urinary Catheters Companies – Pipeline Products by Stage of Development 17

4.2 Urinary Catheters – Pipeline Products by Stage of Development 19

5 Urinary Catheters Companies and Product Overview 21

5.1 All India Institute of Medical Sciences Company Overview 21

5.1.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 21

5.2 Aurie Company Overview 22

5.2.1 Aurie Pipeline Products & Ongoing Clinical Trials Overview 22

5.3 Biocrede Inc Company Overview 23

5.3.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.4 BioModics ApS Company Overview 24

5.4.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 24

5.5 Brighton Development LLC Company Overview 25

5.5.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 25

5.6 Camstent Ltd Company Overview 26

5.6.1 Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.7 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 29

5.7.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 29

5.8 Chain Antimicrobials Ltd Company Overview 30

5.8.1 Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 30

5.9 Coloplast A/S Company Overview 31

5.9.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 31

5.10 Control Flo Medical LLC Company Overview 35

5.10.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.11 ConvaTec Group Plc Company Overview 36

5.11.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 36

5.12 Dongguan TT Medical Inc Company Overview 39

5.12.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.13 Enox Biopharma Inc (Inactive) Company Overview 40

5.13.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 40

5.14 Flat Medical Inc Company Overview 41

5.14.1 Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Flume Catheter Co Ltd Company Overview 43

5.15.1 Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 43

5.16 FocusStart LLC Company Overview 46

5.16.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 46

5.17 Ingenion Medical Ltd Company Overview 47

5.17.1 Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.18 InterVaal Pte Ltd Company Overview 49

5.18.1 InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 Laborie Medical Technologies Inc Company Overview 50

5.19.1 Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 50

5.20 Leading Age Supplies LLC Company Overview 51

5.20.1 Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 51

5.21 Montana State University Company Overview 52

5.21.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 52

5.22 N8 Medical LLC Company Overview 53

5.22.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 53

5.23 Olympus Endo Technology America Inc Company Overview 54

5.23.1 Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 54

5.24 OTU Medical Inc Company Overview 55

5.24.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 55

5.25 Provenmed Company Overview 57

5.25.1 Provenmed Pipeline Products & Ongoing Clinical Trials Overview 57

5.26 Pyriscence LLC Company Overview 58

5.26.1 Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 58

5.27 Riocath Global AS Company Overview 59

5.27.1 Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 59

5.28 Sharklet Technologies Inc Company Overview 64

5.28.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 64

5.29 The University of Nottingham Company Overview 65

5.29.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 65

5.30 Tractivus SL Company Overview 66

5.30.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 66

5.31 University of Amsterdam Company Overview 67

5.31.1 University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 67

5.32 University of California San Diego Company Overview 68

5.32.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 68

5.33 University of South Florida Company Overview 69

5.33.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 69

5.34 University of Texas Health Science Center at San Antonio Company Overview 70

5.34.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 70

5.35 University of Utah Company Overview 71

5.35.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 71

5.36 UroDeflect Company Overview 72

5.36.1 UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 72

5.37 UroDev Medical Company Overview 73

5.37.1 UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 73

5.38 Xennovate Medical LLC Company Overview 76

5.38.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 76

6 Urinary Catheters- Recent Developments 77

6.1 May 15, 2023: INVO reports Q1 2023 financial results 77

6.2 May 15, 2023: SeaStar Medical reports Q1 2023 financial results and provides a business update 79

6.3 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023 81

6.4 May 05, 2023: Bactiguard Holding: Bulletin from annual general meeting 2023 81

6.5 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook 82

6.6 Apr 27, 2023: Bactiguard Holding report for the first quarter 2023 83

6.7 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information 85

6.8 Apr 17, 2023: INVO Reports Fourth Quarter and Full Year 2022 Financial Results 85

6.9 Apr 12, 2023: Medtronic has a layoff in California 87

6.10 Apr 10, 2023: Henry Ford Health Appoints New Orthopedics Chair and Medical Director 87

6.11 Apr 05, 2023: Bactiguard Holding Annual Report 2022 88

6.12 Apr 03, 2023: Notice to attend the Annual General Meeting of Bactiguard Holding AB 89

6.13 Mar 30, 2023: INVO Provides Preliminary Update on FY2022 Financial Results 90

6.14 Mar 22, 2023: ConvaTec Group Notice of Annual General Meeting 91

6.15 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company 92

6.16 Mar 09, 2023: ConvaTec Group Announces Annual Results for the twelve months ended 31 December 2022 92

6.17 Mar 09, 2023: Covalon Announces Voting Results from Fiscal 2022 Annual and Special Meeting of Shareholders 93

6.18 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results 94

6.19 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference 98

6.20 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information 98

6.21 Feb 03, 2023: Coloplast Announcement Interim Financial Report Q1 2022/23 98

6.22 Jan 31, 2023: Coloplast Finance Announces Annual General Meeting Decisions 99

6.23 Jan 25, 2023: Dentsply Sirona Is Said to Weigh $1 Billion Split of Wellspect 100

6.24 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer 100

6.25 Dec 01, 2022: Coloplast Announcement no. 13/2022 Decisions at the Annual General Meeting 2022 100

6.26 Nov 23, 2022: Medtronic Reports Quarterly Earnings 101

6.27 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 101

6.28 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 107

6.29 Nov 14, 2022: Dentsply Sirona Reports Third Quarter 2022 Results 107

6.30 Nov 14, 2022: INVO Bioscience Reports Third Quarter 2022 Financial Results 108

6.31 Nov 08, 2022: Coloplast Notice of Annual General Meeting 109

6.32 Nov 07, 2022: Coloplast Announcement no. 10/2022 – Annual Report 2021/22 & Remuneration Report 2021/22 110

6.33 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022 110

6.34 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook 111

6.35 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information 111

6.36 Sep 28, 2022: Covalon to Participate in the 12th International Pediatric Intestinal Failure and Rehabilitation Symposium in Toronto 111

6.37 Sep 26, 2022: Covalon to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting 113

6.38 Sep 08, 2022: Robert G. Riney Named Henry Ford Health President and CEO 114

6.39 Sep 07, 2022: Medtronic to appear at September investor conferences 115

6.40 Sep 05, 2022: Sanofi announce Evolution of the Board of Directors 115

6.41 Aug 29, 2022: Covalon Announces Third Quarter Fiscal 2022 Results 116

6.42 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 117

6.43 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 119

6.44 Aug 20, 2022: Herbert Smith Freehills advises Sanofi on €300 million equity investment in Innovent 122

6.45 Aug 17, 2022: Coloplast Finance Announces 9M Interim Financial Report 2021/2022 122

6.46 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 123

6.47 Aug 15, 2022: INVO Bioscience Reports Second Quarter 2022 Financial Results 124

6.48 Aug 10, 2022: Medline releases 2021 Corporate Social Responsibility Report 125

6.49 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022 126

6.50 Aug 01, 2022: Audrey Derveloy appointed President of Sanofi France 127

6.51 Jul 28, 2022: Sanofi’s half-year financial report for 2022 127

6.52 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 127

6.53 Jun 07, 2022: Teleflex launches new arrow pressure injectable midline catheter in Europe, the Middle East and Africa region 128

7 Appendix 130

7.1 Methodology 130

7.2 About GlobalData 133

7.3 Contact Us 133

7.4 Disclaimer 133

Frequently asked questions

Urinary Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Urinary Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Urinary Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Urinary Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.